JHJoost Hutsebaut

Joost Hutsebaut

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Joost Hutsebaut has a total of 95 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Exploring the Feasibility of a Generic Early Intervention Programme for Emerging Personality Disorder in Adolescents: Guideline‐Informed Treatment for Personality Disorders—Adolescent Version (GITPD‐A)

    by Paulien Jansen, Jacquelijne Schraven, Sarah Laschen, Stephan Kraai, Joost Hutsebaut

    The Guideline‐Informed Treatment for Personality Disorders—Adolescent version (GITPD‐A) is an accessible, general approach to treating personality disorders (PDs) in adolescents. This study assessed the feasibility of the intervention and of a multicentre research design, as a preliminary step towards larger, better‐controlled trials. A one‐group pretest–posttest design was used across five mental healthcare institutions. Eligible participants were adolescents aged 12–18 meeting threshold criteria for a PD under the DSM‐5 alternative model. Participants (91.9% female; mean age 15.9 years) received GITPD‐A for 6 months. Intervention feasibility was evaluated via paired‐samples t ‐tests on pre‐ and posttest scores. Feasibility of the multicentre design was assessed by eligibility and enrolment rates, measure completion and study dropout. Significant improvement was found for pathological personality traits (PID‐5), with a medium effect size (Hedges' g = 0.50). Secondary outcomes showed significant reductions in depression, anxiety, emotion dysregulation and symptoms of borderline PD. Participants reported high satisfaction ( M = 8.1). Following a broad screening process involving 245 participants, 65 were found to be eligible. Of these, 47 adolescents took part in the study overall, with 38 completing the intervention. The treatment dropout rate was 19.1% ( n = 9). Despite the limited sample, preliminary findings support the feasibility of GITPD‐A for adolescents with emerging PD, showing high acceptability, satisfaction, retention and acceptance of scientific assessments. Selected measures appear suitable for detecting intervention‐related changes. However, a different primary outcome and improved screening strategies may be needed.

  • Latent Structure and Incremental Validity of the Semi‐Structured Interview for Personality Functioning DSM‐5 (STiP‐5.1) in a Lithuanian Adolescent Sample

    by Agnė Grigaitė, Elena Gaudiešiūtė, Joost Hutsebaut, Rasa Barkauskienė

    As personality functioning has become central to contemporary conceptualizations of personality pathology, understanding its structure and optimal assessment has emerged as an important research priority, particularly in adolescence. This study examined the latent structure of the Semi‐Structured Interview for Personality Functioning DSM‐5 (STiP‐5.1) and its incremental validity in predicting functional impairment beyond self‐reported personality functioning. Participants were 178 adolescents aged 11–18 years, including a clinical sample ( n = 104) and a community sample ( n = 74). Confirmatory factor analyses (CFA) and bifactor modeling were used to evaluate the latent structure of the STiP‐5.1. Hierarchical regression analyses examined whether clinician‐rated personality functioning explained additional variance in functional impairment (WHODAS 2.0) beyond self‐reported personality functioning assessed with the LoPF‐Q 12–18 Short. The bifactor model demonstrated the best overall fit and supported the predominance of a strong general factor. Most reliable variance was attributable to this factor, whereas self‐ and interpersonal‐specific factors contributed little unique variance. A four‐factor CFA model also demonstrated excellent fit, supporting differentiation among identity, self‐direction, empathy, and intimacy. Clinician‐rated personality functioning explained additional variance in functional impairment beyond self‐report measures. Self‐functioning, particularly the element of self‐direction, emerged as a unique predictor of functional impairment. Findings support a predominantly unidimensional conceptualization of personality functioning in adolescence while retaining clinically meaningful differentiation across LPFS domains and elements. The STiP‐5.1 provides unique information beyond self‐report assessment, supporting multimethod approaches to the assessment of personality functioning in adolescents.


  • Clinical staging and risk profiling in borderline personality disorder: An evaluation of reliability and clinical utility.

    by Rosie Kidane, Jarco Wesdorp, Stefanie Duijndam, Andrew M. Chanen, Barbara de Clercq, Joost Hutsebaut

    To address the need for a more dynamic assessment of the progress and severity of borderline personality disorder (BPD), as well as associated treatment needs, various models of clinical staging and risk profiling have been proposed. Clinical staging involves estimating disorder severity along a continuum, whereas risk profiling predicts progression across stages using known risk factors. This study examines these models' reliability and clinical utility in predicting dosage (total registered units of direct patient contacts) and outcome for BPD patients. We used anonymized information from patient records of 128 patients treated for (subthreshold) BPD in the Netherlands (M age = 30.51, SD = 11.85; range: 14-61 years). After establishing interrater reliability, a retrospective analysis of routine clinical data was used to examine the relationship between two clinical staging models and one risk profile model on total treatment dosage and outcome. The results showed that staging models and risk profiles could be reliably assessed and that patients in earlier stages required less treatment and achieved better outcomes compared with later stages. However, the contribution of risk profiling was minimal and insignificant. Furthermore, results suggest that the transition from Stage 1 to Stage 2 represents a critical turning point in BPD progression and underscores the importance of early intervention. Despite limitations, clinical staging models explained significant variance in treatment dosage and symptom reduction, offering valuable insights into BPD treatment needs. The study highlights the potential of these models to support early detection and intervention by improving prognosis and guiding more personalized treatment. (PsycInfo Database Record (c) 2026 APA, all rights reserved).

  • Open Access

    Transdiagnostic risk profiling for poor prognosis: a Delphi study

    by Sharon L. Clarke, Joost Hutsebaut, Nathan Bachrach, Christel J. Hessels, Tom Smeets

  • A Brief Report on the Implementation of the Alternative Model for Personality Disorders in Clinical Practice

    by Joost Hutsebaut, Laura C. Weekers, Hilde De Saeger

    The Alternative DSM-5 Model for Personality Disorders (AMPD) was introduced in the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders as a dimensional alternative to the traditional categorical model. Despite considerable research, systematic implementation in clinical practice has remained limited. This article reports on the implementation of the AMPD in an institution that specializes in the assessment and treatment of personality disorders to offer guidance for other teams considering the adoption of the AMPD. Implementation involved developing a multimethod assessment procedure and a training and supervision program, reformulating treatment inclusion criteria in AMPD terms, and developing communication strategies for internal and external stakeholders. Both barriers to and benefits of implementing the AMPD are discussed. Surveys conducted 2 and 4 months after implementation showed that clinicians were increasingly positive, reported growing competence, and generally favored AMPD-based assessments over the traditional assessments. These first experiences suggest that transitioning to the AMPD model is feasible and clinically meaningful.

  • Open Access

    The effectiveness of generalist (GIT-PD) versus specialist treatment (MBT/ST) for severe personality disorders (Personality Disorders Access to Effective Treatment, P-DAET): study protocol of a pragmatic randomised controlled non-inferiority multicentre trial

    by Christel Bomhof, Jan Philipp Löffler, Suzanne Brugman, Paul Lodder, Arne van Den End, Maarten Kornelis van Dijk, Maarten van Westen, Loek van Dam, Ilse Wielaard, Wendy Mensink, et al.

    Background: Personality disorders (PDs) are highly prevalent, impairing, and societally burdening conditions which can be treated effectively. Specialist psychotherapies are the first-choice treatment, but accessibility is hampered by implementation and sustainability issues. Manualised generalist treatments were designed as active control conditions to specialist psychotherapies in several effectiveness trials; their comparable performance led to them being regarded as more accessible alternatives to specialist psychotherapies. The Guideline-Informed Treatment for PDs (GIT-PD) is such a generalist treatment, which has shown promise and is broadly disseminated in the Netherlands and Belgium. However, there is an urgent need for controlled head-to-head comparisons of generalist and specialist treatments for PDs. Therefore, this study poses three main questions: 1) Is generalist treatment non-inferior compared to specialist treatment for severe PDs? 2) Is generalist treatment cost-effective compared to specialist treatment? 3) Which combination of patient characteristics predicts differential treatment outcomes between generalist and specialist treatments? Methods: P-DAET is a pragmatic multicentre randomised controlled non-inferiority trial. In total, 358 adult treatment-seeking participants with severe PDs will be included in five Dutch mental healthcare institutions. Participants are equally randomised to manualised generalist (GIT-PD) or specialist treatment (Mentalisation-Based Treatment/Schema Therapy). The primary outcome is improvement in personality functioning, assessed through assessor-blinded clinical interviews and supplemented with self-report questionnaires. Symptom severity and psychosocial functioning are important secondary outcomes. Participants complete assessments at 7 time-points: baseline (T0), 3 (T1), 6 (T2), 12 (T3), 18 (T4), 24 (T5), and 30 months (T6) after the start of treatment. The primary endpoint is at 18 months. An economic evaluation will be executed alongside the RCT. Differential treatment response based on candidate predictors at the patient level will be explored using a personalised advantage index (PAI). Discussion: P-DAET will determine the (cost-)effectiveness of generalist versus specialist treatment for severe PDs. This study will provide novel insights into the applicability of these treatments and their differential treatment response, enabling effective and personalised allocation of limited specialist treatment resources, while contributing to more accessible and good-enough care for individuals with severe PDs. Trial registration: ClinicalTrials.gov: NCT06789380. Retrospectively registered on February 5, 2025.


  • The Clinical Utility of the Level of Personality Functioning Scale: A Treatment Perspective

    by Joost Hutsebaut, Donna S. Bender

    The Level of Personality Functioning Scale (LPFS) was introduced in DSM-5 to articulate a conceptual foundation for all types of personality psychopathology, and to provide an assessment of the severity of impairment. Constructed using universal human capacities related to self- and interpersonal functioning, the LPFS defines a continuum of 5 levels ranging from optimal functioning to extreme impairments in functioning. While there have been a growing number of empirical studies demonstrating its reliability and validity, the LPFS was designed fundamentally as an informative clinical tool, potentially useful to practitioners working in a variety of roles using diverse interventions. This article addresses the issue of treatment utility from 2 particular perspectives. First, we illustrate how the capacities targeted by the LPFS offer a framework for treatment, applicable to a variety of theoretical or methodological orientations. We illustrate that the different facets of the LPFS may provide general aims for treatment by identifying the pathways through which change is realized in (whatever) psychotherapy. Second, we suggest how the levels of functioning may inform pathways toward change by providing information useful for treatment assignment and planning, such as the therapist's stance, the types of intervention, and specific goals in treatment. Through discussing these issues while using brief clinical vignettes, we hope that this article may stimulate clinicians to use the LPFS and discover its value in clinical practice.


  • First psychometric evaluation of the Level of Personality Functioning Scale—Brief Form 2.0 in adolescents.

    by Julianne Wu, Madeleine Allman, Kennedy Balzen, Joost Hutsebaut, Carla Sharp

    Reflecting the recent consensus that challenges in personality functioning often onsets in adolescence, and the move toward dimensional models of personality pathology such as the level of personality functioning (LPF) of the alternative model for personality disorders, it is important to have validated measures that can assess LPF in young people. The Level of Personality Functioning Scale-Brief Form 2.0 (LPFS-BF 2.0) is the briefest measure of LPF and may be particularly well suited for assessing LPF in youth; however, it has yet to be formally validated in youth. Therefore, the current investigation evaluated the psychometric properties of the LPFS-BF 2.0 in adolescents drawn from a community sample of ethnically diverse North American youth (N = 194, age 12-18; 58% female). Factor structure, gender invariance, reliability, convergent validity, incremental validity, and criterion validity were evaluated. Results demonstrated support for the LPFS-BF 2.0's unidimensional factor structure, as well as high internal consistency. Configural, metric, and scalar measurement invariance was supported across male and female genders, as well as convergent validity. Relative to the Personality Inventory for the DSM-5 Brief Form and Levels of Personality Functioning Questionnaire 12-18, the LPFS-BF 2.0 demonstrated additional variance in predicting borderline personality features, and internalizing and externalizing problems. Study findings support the English version of the LPFS-BF 2.0 as a brief and psychometrically sound instrument for assessing LPF in youth and adolescents. (PsycInfo Database Record (c) 2024 APA, all rights reserved).


  • Comparing the clinical utility of the alternative model for personality disorders to the Section II personality disorder model: A randomized controlled trial.

    by Laura C. Weekers, Joost Hutsebaut, Hilde De Saeger, Jan H. Kamphuis

    The alternative model for personality disorders (AMPD) has been extensively studied over the past decade, but to date there is no direct comparison of the clinical utility of the AMPD model relative to the Section II personality disorder (PD) model in an ecologically valid design. The current study examined the clinical utility of an AMPD-informed assessment procedure and Section II PD assessment procedure as assessed by both patients and clinicians in a randomized controlled trial. A sample of 119 patients were randomly assigned to either an AMPD or a Section II PD assessment procedure. At the end of the assessment, patients filled out questionnaires pertaining to clinical utility, satisfaction, motivation for treatment, and general experience of the assessment. Clinicians who subsequently started treatment with these patients also completed two clinical utility questionnaires. There were no significant differences between the AMPD and Section II PD assessment procedure on patients' reported clinical utility, motivation for treatment, satisfaction, and general experience of the assessment nor were there significant differences between the models on clinician reported clinical utility. Explorative analyses revealed that, for patients, a positive relationship with the assessor was predictive of experienced utility. This study shows no superiority of the AMPD in terms of clinical utility but suggests that the alliance with the assessor is a particularly salient factor in clinical utility.